SequelSEC

Regenerative Medical Technology Group Inc. RMTG

Retail-Retail Stores, NEC · CIK 0001760026 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$9.41M
Fiscal year ended 2026-06-30
Operating income
$43.72K
Fiscal year ended 2026-06-30
Free cash flow
-$582.33K
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$612.54KMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.05Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Retail-Retail Stores, NEC filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue11.8%100th
FCF margin-25.7%0th
Current ratio0.03x8th
Net margin-153.2%9th
Revenue YoY growth24.2%91th
Gross margin55.1%82th
Operating margin-17.0%18th

Regenerative Medical Technology Group Inc. (RMTG) reported revenue of $9.41M and net income of -$9.53M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Regenerative Medical Technology Group Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Retail-Retail Stores, NEC.

Income

Regenerative Medical Technology Group Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$9.41M
Cost of revenue$3.79M
Gross profit$5.63M
Operating income$43.72K
Net income-$9.53M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$1.76M
Selling & marketingUnavailable

Balance

Regenerative Medical Technology Group Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$1.32M
Total assets$5.85M
Current assets$2.28M
Total liabilities$45.11M
Current liabilities$42.61M
Total equity incl. NCI-$39.26M
Temporary (mezzanine) equityUnavailable
Inventory$481.17K
Accounts receivable$110.24K
Goodwill$1.68M
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Regenerative Medical Technology Group Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$268.56K
Capital expenditures$850.89K
Investing cash flow-$850.89K
Financing cash flow$291.38K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$362.92K

Derived

Regenerative Medical Technology Group Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$582.33K
Gross margin59.8%
Operating margin0.5%
FCF margin-6.2%
SBC / revenueUnavailable
Current ratio0.05x
Revenue YoY growth94.3%
Net margin-101.2%
R&D / revenueUnavailable
CapEx / revenue9.0%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RMTG in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-06-09View SEC filing
10-K · Filed 2026-05-14View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-05-20View SEC filing

Companies in the same industry

BARK BBWI FLWS INHD LESL NSTM RENT SBH SGU TITN ULTA WOOF

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.